National Association of Professional Women Announces Ruth E. Hager, B.S.N., R.N. Director Drug Safety and Pharmacovigilance at Ziopharm Onco, as VIP Woman of the Year

Ruth E. Hager is recognized as an NAPW VIP Woman of the Year for her outstanding leadership and commitment within her profession.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
My expertise is pharmaceutical vigilance, management, drug safety and healthcare.

Garden City, NY (PRWEB) February 25, 2014

NAPW honors Ruth E. Hager as a 2013/2014 Professional Woman of the Year for leadership with this prestigious distinction. As the largest, most-recognized organization of women in the country, spanning virtually every industry and profession, the National Association of Professional Women is a powerfully vibrant networking community with over 600,000 members and nearly 400 Local Chapters.

“My expertise is pharmaceutical vigilance, management, drug safety and healthcare,” said Ms. Hager, who holds a Bachelor of Science in Nursing from Northeastern University.

Ziopharm Oncology is a leading Boston, Massachusetts-based biotechnology company “employing novel gene expression and control technology to deliver DNA for the treatment of cancer.” Before joining Ziopharm Oncology, Ms. Hager held a number of key positions in the pharmacology/biotechnology industry, including tenure as an associate director at Vertex, a senior manager pharmacovigilance at MedImmune and a safety monitor at Biogen Idec.

At Ziopharm, Ms. Hager has the critical task of overseeing the safety department, which is responsible for the compliance of adverse event reports for the products in development. Her ultimate responsibility is to work with the team of physicians to ensure the products we are working on are developed to maximize benefit and minimize risk to the patients.

A consummate professional, Ms. Hager is committed to staying on top of the latest innovations and changes in the pharmacology/biotechnology industry. She is currently involved with the Drug Information Association (DIA) and Advancing Women in the Business of Science and Technology (WEST).

NAPW provides an exclusive networking forum to professional women where they can aspire, connect, learn and achieve. Through innovative resources, unique tools and progressive benefits, member interact, exchange ideas, advance their knowledge and empower each other.


Contact

  • Ruth E. Hager

    978-828-1480
    Email

Attachments

Ruth E. Hager, B.S.N., R.N. Ruth E. Hager, B.S.N., R.N.

Director Drug Safety and Pharmacovigilance, Ziopharm Onco